THANKTASTIC
LIVE

Serial Number

98456607

Owner

ImmunityBio, Inc.

Attorney

Alicia M. Passerin

Filing Date

Mar 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

THANKTASTIC Trademark

Serial Number: 98456607

THANKTASTIC is a trademark filed by ImmunityBio, Inc. on March 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

ImmunityBio, Inc. (6 trademarks)

3530 John Hopkins Court
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

March 19, 2024

Registration Date

Not Registered

Published for Opposition

November 5, 2024

Goods & Services

Medical services; medical information; providing a website featuring medical information in the fields of pharmaceuticals, immunotherapy, immuno-oncology, cancer, autoimmune diseases, and infectious diseases; providing medical information relating to pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases

Pharmaceutical preparations and substances for the treatment of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical preparations and substances for the prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; biological preparations for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases and infectious diseases in the fields of immunotherapy and immuno-oncology; anti-infectives for medical use for the treatment and prevention of immunologic dysfunction, autoimmune diseases and infectious diseases

Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 29, 2026 EXRA
SOU EXTENSION 3 GRANTED
May 28, 2026 EX3G
SOU EXTENSION 3 FILED
May 28, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
May 28, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2025 EXRA
SOU EXTENSION 2 GRANTED
Dec 7, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 7, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 7, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jun 4, 2025 EX1G
SOU EXTENSION 1 FILED
Jun 4, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 4, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 17, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2024 CNSA
ASSIGNED TO EXAMINER
Sep 26, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 13, 2024 NWOS
NEW APPLICATION ENTERED
Mar 19, 2024 NWAP